Grants and Contributions:
Title:
Kisoseek: A biotechnology platform for SdAb selection for cancer treatment
Agreement Number:
993405
Agreement Value:
$550,000.00
Agreement Date:
Jul 1, 2022 - Oct 31, 2023
Description:
Through the development and application of cutting-edge machine learning algorithms, the firm seek to build an end-to-end AI-enabled platform, KisoSeek, that will use machine learning to search and identify therapeutic cancer antibodies.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2X 2J1
Reference Number:
172-2022-2023-Q2-993405
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
858257454
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 32 days. The total amended value is 50,000 dollars.
Amendment Date
Sep 28, 2023
Recipient's Legal Name:
Kisoji Biotechnologie Inc.
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: